Children and young adults living in states with the biggest drops in Medicaid coverage experienced more prescription disruptions for their chronic conditions than those living in states with smaller drops, according to a new study by researchers at the University of Michigan.
More children and young adults with chronic conditions such as depression and asthma experienced prescription disruptions in states with the biggest drops in Medicaid enrollment during the “unwinding process” when compared to states with smaller drops, according to a recent study done by the University of Michigan and published in Pediatrics.
This study was conducted by a team at the University of Michigan’s Susan B. Meister Child Health Evaluation and Research Center (CHEAR) and led by Kao-Ping Chua, M.D., Ph.D., a pediatrician and health care researcher at the University of Michigan Medical School and School of Public Health.
“Our findings suggest that the rapid disenrollment of young people from Medicaid during the unwinding process resulted in the disruption of chronic disease therapy,” Chua said in the study. “As policymakers debate whether to enact drastic cuts to Medicaid funding, they should consider the possibility that doing so could similarly disrupt chronic disease therapy for children and young adults, placing them at higher risk for disease exacerbations and absenteeism from school and work.”
Chua and his team analyzed prescription data from patients ages 0 to 25 using the 2017–2023 IQVIA Longitudinal Prescription Database, which captures data from 92% of prescriptions filled at U.S. pharmacies. The medications were organized into five classes:
Young adults ages 19 to 25 were the age group most likely to stop filling prescriptions due to loss of Medicaid coverage if they lived in states that had bigger drops in adult Medicaid enrollment, compared with those living in states with smaller drops. Young adults living here had a decrease in prescriptions for 2 classes and were at risk for having no prescriptions or 1 or more cash-pay prescriptions for all classes.
"One potential reason is that parents may be willing to make great financial sacrifices to pay for their child’s medications even if the child loses Medicaid coverage and becomes uninsured," Chua said in an email interview. "Young adults do not always have access to their parents’ financial resources."
For young adult disenrollment, states such as Idaho, Kansas and Montana saw disenrollment rates of 19% or more on the higher end. The smallest drops (8% or less) occurred in states such as Nevada, Virginia and Wisconsin.
Seventeen percent of children living in high disenrollment states saw a drop in prescription access, specifically, a decrease in prescriptions for at least 1 class and a risk of decrease in 1 or more cash-pay prescriptions for 3 classes. The states with the smallest drops, including Maryland, Maine and North Carolina, saw enrollment drops of 4% or less.
During the COVID-19 pandemic, states continuously enrolled Medicaid beneficiaries in exchange for increased federal funding due to Congress’s Families First Coronavirus Response Act (FFCRA). This resulted in a total of 94 million enrollees in March 2023—up 23 million from the previous year. As of April 1, 2023, states have been ending coverage for people deemed ineligible or whose redetermination can’t be completed. As of Sept. 12, 2024, more than 25 million people have been disenrolled and more than 56 million have had their coverage renewed. Among those who were disenrolled, 69% were disenrolled because of paperwork or procedural reasons, according to KFF data.
“To reverse these disruptions, policymakers could find alternative sources of coverage for disenrolled patients who are no longer eligible for Medicaid and reenroll eligible patients who were disenrolled from Medicaid for procedural
reasons,” Chua and his team write in the study. “To reverse disruptions among young adults specifically, policymakers in states that have not expanded Medicaid under the Affordable Care Act could consider doing so, as such expansions have been particularly beneficial for young adults with low income.”
FDA Approves First At-Home Cervical Cancer Screening Device
May 15th 2025Self-collected samples to test for cervical cancer are a step in the right direction when it comes to addressing healthcare barriers, according to Rahma S. Mkuu, Ph.D., M.P.H., assistant professor in the Department of Health Outcomes & Biomedical Informatics at the University of Florida College of Medicine.
Read More
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
The First Financial Toxicity Tumor Board Reports Success in Individual Patient Savings
May 14th 2025Financial toxicity can affect patient outcomes and quality of life. For example, a patient may forgo treatment or medications to save money, or they may incur high medical debt or go into bankruptcy to pay for medical care.
Read More